Principia Biopharma Inc. (PRNB) is a publicly traded company in the Unknown sector. Across all available filings, 17 corporate insiders have executed 156 transactions totaling $123.3M, demonstrating a bullish sentiment with $15.5M in net insider flow. The most recent transaction on Sep 28, 2020 involved a transaction of 1,023 shares valued at $102.3K.
No significant insider buying has been recorded for PRNB in the recent period.
No significant insider selling has been recorded for PRNB in the recent period.
Based on recent SEC filings, insider sentiment for PRNB is bullish with an Insider Alignment Score of 56/100 and a net flow of $15.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Principia Biopharma Inc. (PRNB) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 17 insiders are actively trading PRNB stock, having executed 156 transactions in the past 90 days. The most active insider is Simeon George (Executive), who has made 8 transactions totaling $312.9M.
Get notified when executives and directors at PRNB file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Sep 28, 2020 | Babler Martin | Executive | Tender | 1,023 | $100.00 | $102.3K | |
| Sep 28, 2020 | Babler Martin | Executive | Tender | 18,355 | $100.00 | $1.8M | Large |
| Sep 28, 2020 | Babler Martin | Executive | Tender | 39,179 | $100.00 | $3.9M | Large |
| Sep 28, 2020 | M. Goldstein David | Executive | Tender | 31,826 | $100.00 | $3.2M | Large |
| Sep 28, 2020 | Y. Chai Christopher | Executive | Tender | 3,799 | $100.00 | $379.9K | |
| Sep 28, 2020 | Y. Chai Christopher | Executive | Tender | 3,302 | $100.00 | $330.2K | |
| Sep 28, 2020 | C. Hardiman Roy | Executive | Tender | 1,916 | $100.00 | $191.6K | |
| Sep 28, 2020 | C. Hardiman Roy | Executive | Tender | 117,761 | $100.00 | $11.8M | Large |
| Sep 28, 2020 | Thomas Dolca | Executive | Tender | 2,207 | $100.00 | $220.7K | |
| Sep 28, 2020 | Wolff Stefani | Executive | Tender | 13,592 | $100.00 | $1.4M | Large |
| Sep 28, 2020 | J. Becker Daniel | Executive | Tender | 667,600 | $100.00 | $66.8M | Large |
| Sep 28, 2020 | George Simeon | Executive | Tender | 2,982,855 | $100.00 | $298.3M | Large |
| Sep 18, 2020 | C. Hardiman Roy | Executive | Sale | 5,000 | $99.98 | $499.9K | |
| Sep 18, 2020 | C. Hardiman Roy | Executive | Option Exercise | 2,242 | $7.27 | $16.3K | |
| Sep 18, 2020 | C. Hardiman Roy | Executive | Option Exercise | 2,758 | $4.72 | $13.0K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Tender(U) | 12 | $388.3M | 75.7% |
Purchase(P) | 13 | $69.4M | 13.5% |
Sale(S) | 62 | $53.9M | 10.5% |
Exercise(M) | 25 | $1.1M | 0.2% |
Gift(G) | 7 | $0 | 0.0% |
Conversion(C) | 37 | $0 | 0.0% |
Insider activity at Principia Biopharma Inc. shows mixed signals across all time. While $69.4M in purchases indicates some executive confidence,$53.9M in sales balances the picture, resulting in a modest net flow of $15.5M.17 insiders have been active, with no strong directional conviction evident in the aggregate data. The most active insider, Simeon George, has transacted $312.9M during this period.